Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;32(9):3733-42.

Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes

Affiliations

Novel vitamin D hydroxyderivatives inhibit melanoma growth and show differential effects on normal melanocytes

Andrzej T Slominski et al. Anticancer Res. 2012 Sep.

Abstract

Background/aims: To test the activity of novel hydroxyvitamin D(3) analogs (20(OH)D(3), 20,23(OH)(2)D and 1,20(OH)(2)D(3)) on normal and malignant melanocytes in comparison to 1,25(OH)(2)D(3).

Materials and methods: Human epidermal melanocytes and human and hamster melanoma cells were used to measure effects on proliferation and colony formation in monolayer and soft agar. Cell morphology and melanogenesis were also analyzed. QPCR was used to measure gene expression.

Results: Novel secosteroids inhibited proliferation and colony formation by melanoma cells in a similar fashion to 1,25(OH)(2)D(3), having no effect on melanogenesis. These effects were accompanied by ligand-induced translocation of VDR to the nucleus. In normal melanocytes 1α-hydroxyderivatives (1,25(OH)(2)D(3) and 1,20(OH)(2)D(3)) had stronger anti-proliferative effects than 20(OH)D(3) and 20,23(OH)(2)D(3), and inhibited dendrite formation. The cells tested expressed genes encoding VDR and enzymes that activate or inactivate vitamin D(3).

Conclusion: Novel secosteroids show potent anti-melanoma activity in vitro with 20(OH)D(3) and 20,23(OH)(2)D(3) being excellent candidates for pre-clinical testing.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures and enzymatic methods of production of novel vitamin D3 hydroxy-derivatives.
Figure 2
Figure 2
Comparison of the anti-proliferative activity of the vitamin D derivatives 1,25(OH)2D3, 20(OH)D3, 20,23(OH)2D3 and 1,20(OH)2D3 between cultured normal human epidermal melanocytes (A) and human SKMel-188 melanoma cells (B). The cells were treated with the secosteroids (10–7 M) for 7 days and their numbers were counted. Data are shown as mean±SD (n=3); *p<0.05; **p<0.01; ***p<0.001. 1,25(OH)2D3 and 1,20(OH)2D3, but not 20(OH)D3 or 20,23(OH)2D3 inhibited dendrite formation (C). The differences between ethanol-treated control and treatments were analyzed by student's t-test
Figure 3
Figure 3
Novel vitamin hydroxyderivatives inhibit DNA synthesis in human melanoma cells. YUROB cells were treated for 48 h with 1,25(OH)2D3, 20(OH)D3, 20,23(OH)2D3, or 1,20(OH)2D3 (10–7 M) and the rate of 3H-thymidine incorporation into DNA served as a measure of proliferative activity. Data are presented as mean±SD (n=4). Statistical significance was estimated using one-way ANOVA Incorporation into DNA is shown as a percentage (%) of control (ethanol-vehicle treated cells). *p<0.05 and ***p<0.001.
Figure 4
Figure 4
Novel vitamin D hydroxyderivatives inhibit the ability of human melanoma cells to form colonies in monolayer (platting efficiency). SBCE2 cells were plated at a density 20 cells/cm2, grown in the presence or absence of 1,25(OH)2D3, 20,23(OH)2D3 or 1,20(OH)2D3, and after 10 days formation of colonies larger than 0.2 mm (A) or 0.5 mm (B) in diameter was determined. Data are shown as mean±SD (n = 4); statistical significance was estimated using one-way ANOVA and presented as *p<0.05, **p<0.01 and ***p<0.001. Insert shows Western blot detection of VDR in SBCE2 human melanoma cells. The whole extracts from cells were subjected to immunoblotting with anti- VDR, and anti- β-actin (internal control) as described before (3). The numbers on the left in the insert represent molecular weight in kD.
Figure 5
Figure 5
Novel vitamin hydroxyderivatives inhibit the anchorage independent growth (ability to form colonies in soft agar) of hamster melanoma cells. AbC1 melanoma cells were plated in soft agar at 1,000 cells/well and grown in the presence or absence of 1,25(OH)2D3, 20(OH)D3 or 20,23(OH)2D3. After two weeks colonies with a diameter larger than 0.2 mm (A) or 0.5 mm (B) were counted. Data are shown as mean±SD (n=4); statistical significance was estimated using one-way ANOVA and presented as *p<0.05, **p<0.01 and ***p<0.001.
Figure 6
Figure 6
Novel vitamin hydroxyderivatives inhibit the anchorage independent growth (ability to form colonies in soft agar) of human melanoma cells. SKMel-188 human melanoma cells were grown in soft agar in the presence or absence of 1,25(OH)2D3 (A), 20(OH)D3 (B) or 20,23(OH)2D3 (C). Panels A and B are from from the same whilke panel C for separate experiment. After two weeks colonies with a diameter larger than 0.5 mm were counted. Data are shown as mean±SD (n=4); statistical significance was estimated using one-way ANOVA and presented as *p<0.05 and **p<0.001. Insert: representative plates incubated with solvent (ethanol) or 10–7 M secosteroids.
Figure 7
Figure 7
The effect of vitamin D3 derivatives on the translocation of VDR from the cytoplasm to the nucleus. The panel on the right shows photographs of the cells with fluorescent VDR-EGFP fusion protein in the nucleus. The left pannel shows the percentage of cells with fluorescent nuclei. Data are presented as means±SEM (n≥6). The differences between ethanol-treated control and treatment were analyzed by student's t-test: p<0.05 (*), p<0.01 (**).

Similar articles

Cited by

References

    1. Bikle DD. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol. 2011;347:80–89. - PMC - PubMed
    1. Brozyna AA, Jozwicki W, Janjetovic Z, Slominski AT. Expression of vitamin D activating enzyme 1-alpha-hydroxylase (CYP27B1) decreases during melanoma progression. Hum Pathol. 2012 In press. doi:10.1016/j.humpath.2012.03.031. - PMC - PubMed
    1. Brożyna AA, Jozwicki W, Janjetovic Z, Slominski AT. Expression of vitamin D receptor decreases during progression of pigmented skin lesions. Hum Pathol. 2011;42:618–631. - PMC - PubMed
    1. Carlberg C, Molnar F. Current status of vitamin D signaling and its therapeutic applications. Curr Top Med Chem. 2012;12:528–547. - PubMed
    1. Colston K, Colston MJ, Feldman D. 1,25-dihydroxyvitamin D3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrinology. 1981;108:1083–1086. - PubMed

Publication types